![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Edema - 450 Studies Found
Completed |
: Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema : Angioedema : 2009-12-18 : Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin subcutaneous dose of 3 |
Completed |
: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema : Angioedema : 2005-07-29 : Drug: C1 inhibitor concentrate (C1-esteraseremmer-N) every 5-7 days |
Not yet recruiting |
: Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy : Idiopathic Angioedema : 2016-11-15 :
|
Completed |
: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects : Hereditary Angioedema : 2007-02-07 : Drug: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study : Angioedema : 2010-06-29 :
|
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-02-21 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-04-17 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema : Angioedema : 2004-11-26 :
|
Completed |
: Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE : Hereditary Angioedema : 2015-10-23 :
|
Active, not recruiting |
: Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE : Hereditary Angioedema : 2016-04-08 :
|